Latest
Stellar Biotechnologies applies for delisting from TSX Venture Exchange
Port Hueneme-based Stellar Biotechnologies has applied for a voluntary delisting from Canada’s TSX Venture Exchange. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Common shares of Stellar Biotechnologies stock started trading on the Nasdaq stock exchange Nov. 5. The Read More →
